Biophytis S.A.
BPTS · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $803 | $484 | $311 | $280 |
| Gross Profit | -$803 | -$484 | -$311 | -$280 |
| % Margin | – | – | – | – |
| R&D Expenses | $10,406 | $16,034 | $19,665 | $9,921 |
| G&A Expenses | $5,488 | $7,237 | $7,150 | $4,021 |
| SG&A Expenses | $5,488 | $7,237 | $7,150 | $4,021 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1,561 | $0 | $0 | $0 |
| Operating Expenses | $14,333 | $23,271 | $26,815 | $13,942 |
| Operating Income | -$14,333 | -$23,272 | -$26,815 | -$13,942 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$4,254 | -$944 | -$4,349 | -$11,575 |
| Pre-Tax Income | -$18,587 | -$24,216 | -$31,247 | -$17,054 |
| Tax Expense | -$1,561 | $0 | $2,279 | $4,374 |
| Net Income | -$17,026 | -$24,216 | -$31,163 | -$25,517 |
| % Margin | – | – | – | – |
| EPS | -12.55 | -56.06 | -105.64 | -172.41 |
| % Growth | 77.6% | 46.9% | 38.7% | – |
| EPS Diluted | -12.54 | -55.4 | -105.38 | -170.19 |
| Weighted Avg Shares Out | 1,357 | 432 | 295 | 148 |
| Weighted Avg Shares Out Dil | 1,358 | 437 | 296 | 150 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $990 | $20 | $34 |
| Interest Expense | $1,251 | $1,597 | $4,432 | $4,374 |
| Depreciation & Amortization | $529 | $484 | $311 | $280 |
| EBITDA | -$13,804 | -$22,787 | -$26,504 | -$13,662 |
| % Margin | – | – | – | – |